-
Janeji provides precision medical examination programs for enterprise-side customers
Time of Update: 2021-03-02
disease management and other projects, to provide users with personalized and accurate physical examination program and continuous health control services. Customized gene chips, more in line with the genetic Chinese characteristics
-
Luo Qingming: I hope to start the China Brain Program as soon as possible
Time of Update: 2021-03-02
In the 1990s, while studying in the United States, Luo Qingming, who was engaged in photoelectronics research, detected brain activity for the first time in the world using near-infrared optical imaging, and the technology was patented in the United States.
-
AstraZeneia's New Drug Administration program has been approved by the FDA
Time of Update: 2021-02-28
AstraZeneca recently announced that the U.S. Food and Drug Administration (FDA) has approved a new dosage option for the anti-PD-L1 therapy Imfinzi ( Infinfan, generic name: durvalumab, dovalyu monoanti) : a fixed dose of 1500 mg every 4
-
Novartic has signed a choice agreement with icono, which aims to introduce ophthalmology drug research and development programs
Time of Update: 2021-02-25
The company develops innovative therapies based primarily on tissue factor (TF) biology to provide treatment options for patients with cancer and severe retinal disease.
-
J Clin Oncol:R-CHOP program plus lynamine can further improve prognostics in newly diagnosed DLBCL patients
Time of Update: 2021-02-25
in this trial, newly diagnosed International Prognostic Index (IPI) ≥2, ECOG Performance Status≤2 of phase II large block-IV DLBCL patients were randomly assigned to the R2CHOP group and R-CHOP group for a total of 6 cycles.
-
Eur Radiol: A fast and accurate MRI program to diagnose colorectal cancer liver metastasis!
Time of Update: 2021-02-24
-specific contrast agents further improved the diagnostic performance of MR imaging. some studies and Mate analysis have shown that MR imaging with liver-specific contrast agents is significantly better than CT and MR imaging with extracellular
-
The first in the country! Anhui introduced a DIP guidance program for 7 cities pilot
Time of Update: 2021-02-24
process by disease score. First, to reasonably determine the annual regional total budget indicators; the Guidance Program emphasizes that it is effectively connected with the county medical bodies. first, select the types
-
Innovative drug research and development and treatment programs to promote new breakthroughs in AIDS prevention and treatment
Time of Update: 2021-02-24
therapy, Wang Hui introduced, HIV antiviral treatment has experienced many twists and turns, from the beginning only the backbone of drugs, to the back by the backbone of drugs and core drugs composed of "cocktail therapy", the current treatment program
-
JAMA Neurol: Pernisson Shock Therapy combined with a rapid reduction program to treat moderate to severe muscle weakness
Time of Update: 2021-02-24
and there was no recurrence at 15 months. 117 patients were involved in the study, including 58 in the slow-down group, 59 in the fast-reducing group and 62 in men, with an average age of 65. group of 23 reached the main finish line, while the slow-down
-
Gilead and HHS have launched a free drug program
Time of Update: 2021-02-22
Kronstein told NYT that the program won't help people pay for tests or follow-up exams. He added that if HHS did not pay for distribution, the agency would be able to pay for testing for about 6,000 people. Related: After
-
Three-tree paint college students "Yushu" program: Who is the CEO in ten years?
Time of Update: 2021-02-22
Please continue to pay attention to the three tree college students "Yushu" program, quickly join us.
-
Bayer's $335 million investment in gene programming start-up CRISPR has been awarded a joint human test
Time of Update: 2021-02-21
A company that wants to make gene programming a reality has recently won the backing of the world's pharmaceutical giants. Bayer, the German pharmaceutical company valued at $96 billion, will invest at least $300 million over the next five
-
"China Program" for Endoscopic Ultrasound Minimally Invasing Treatment
Time of Update: 2021-02-20
recently, Professor Sun Siyu, Vice President of Shengjing Hospital affiliated with China Medical University, won the second prize of the 2018 National Science and Technology Progress Award for his project "Establishment and Clinical
-
Jilin: Clear five centers to build a "three-step" program
Time of Update: 2021-02-18
clarified the implementation plan for the construction of the five major centers. The Program points out that the construction of the five major centers refers to the establishment of a new medical emergency system with chest pain, stroke, trauma
-
New drug for multiple sclerosis! Plegridy (polyglycol interferon β-1a) intramyal injection program approved by the FDA!
Time of Update: 2021-02-16
February 02, 2021 // -- Biogen recently announced that the U.S. Food and Drug Administration (FDA) has approved Plegridy (polyglycolin interferon β-1a) as a new intramuscular (IM) injection pathway for the treatment of patients with multiple sclerosis (RMS).
-
China has officially joined the "New Crown Vaccine Implementation Program", Ministry of Foreign Affairs announces
Time of Update: 2021-02-15
3, at a regular press conference at the Ministry of Foreign Affairs, spokesman Wang Wenbin said that China has officially joined the "New Crown Vaccine Implementation Plan" and maintained close communication with WHO and other sponsors to work
-
The federal government has announced a new pilot program to stop the illegal online sale of opioids
Time of Update: 2021-02-12
the pilot program, the FDA notifies the Internet registry - Neustar, Verisign and the Public Interest Registry (PIR) - that the agency sends a warning letter to the website operator and the website operator does not respond adequately within the allotted
-
Lancet Haematol: The MATRix-RICE program is effective in treating secondary CNS-soaked diffuse large B-cell lymphoma in a joint self-bodies HSCT
Time of Update: 2021-02-10
at the end of the programme, 46 patients (61 per cent; 95 per cent CI 51-71) received objective remission with a medium duration of 26 months (IQR 16-37).
-
Fda announces pilot program to treat Duching's muscular dystrophy
Time of Update: 2021-02-09
drug suvodirsen (WVE-210201). It is worth mentioning that this is the first clinical trial program to be selected since the CID pilot project was launched in August 2018. Rare diseases such as DMD, often due to the scarcity of test subjects, make
-
Policy interpretation of the Pilot Program for drug listing license holders
Time of Update: 2021-02-08
for the safety, effectiveness and quality control of the drug. , what are the conditions for drug market license holders? drug market license holders shall be pharmaceutical research and development institutions established
